Health care stocks were mostly higher this afternoon, with the NYSE Health Care Index rising 1.6% while the SPDR Health Care Select Sector ETF (XLV) was up 1.8%.

When GBS last reported its balance sheet in September 2021, it had zero debt and cash worth US$13m. Looking at the last year, the company burnt through US$8.5m. That means it had a cash runway of ...

SUNNYVALE, Calif., Nov. 16, 2022 /PRNewswire/ -- Cepheid today announced the availability of Xpert ® GBS LB XC (extended coverage), a molecular diagnostic test for qualitative detection of Group ...

LONDON, Feb. 18, 2020 /PRNewswire/ -- Higher Education provider GBS announces the appointment of a prominent new member to its Advisory Board, enh ...

The BD MAX GBS Assay is an in vitro diagnostic (IVD) test for detection of GBS DNA in Lim Broth cultures - enabling laboratories to comply with the 2010 CDC guidelines for GBS screening.

CANTON, Ga., Feb. 9, 2011 (GLOBE NEWSWIRE) -- GBS Enterprises Inc. (OTCBB:GBSX) has announced that its majority owned subsidiary, GBS Business Software (GBS), a leading provider of IBM Lotus ...